Jillian Elyse Spangler

Title: Jillian Elyse Spangler: Innovator in Anticancer Compounds

Introduction

Jillian Elyse Spangler is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential applications in cancer treatment. With a total of 4 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

One of her latest patents involves Pyrido[4,3-d]pyrimidine compounds. This invention relates to compounds of Formula (I)-(III) and pharmaceutically acceptable salts thereof, focusing on their use in medicine. The compounds may be useful in the treatment, prevention, suppression, and amelioration of diseases, disorders, and conditions such as cancers. Another significant patent includes substituted quinazoline and pyridopyrimidine derivatives, which are useful as anticancer agents. This patent covers compounds of a general formula, processes for their preparation, and their administration to patients for treating pancreatic, lung, colon, and other cancers.

Career Highlights

Jillian is currently employed at Pfizer Corporation, where she continues to advance her research in medicinal compounds. Her work at Pfizer has allowed her to collaborate with leading experts in the field, enhancing the impact of her inventions.

Collaborations

Some of her notable coworkers include Simon Paul Planken and Asako Nagata. Their collaborative efforts contribute to the innovative environment at Pfizer, fostering advancements in cancer treatment.

Conclusion

Jillian Elyse Spangler is a dedicated inventor whose work in developing anticancer compounds is making a significant impact in the medical field. Her innovative spirit and commitment to research are paving the way for future breakthroughs in cancer therapy.